129 results
8-K
ARCT
Arcturus Therapeutics Holdings Inc
19 Mar 24
Regulation FD Disclosure
6:00am
for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical
8-K/A
ARCT
Arcturus Therapeutics Holdings Inc
14 Mar 24
Results of Operations and Financial Condition
9:05am
substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Any statements, other
8-K
EX-99.1
jdh 3t1a7
7 Mar 24
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
4:05pm
8-K
ftbc 40tuek
7 Mar 24
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
4:05pm
8-K
EX-99.1
4vafewiak a5ut
14 Nov 23
Arcturus Therapeutics Announces Third Quarter 2023 Financial Update
4:10pm
8-K
0e5nyq
14 Nov 23
Arcturus Therapeutics Announces Third Quarter 2023 Financial Update
4:10pm
8-K
EX-99.1
8myzyf7zd yf5n
26 Sep 23
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-99.1
bglpkb4x2jr xlzm6x
14 Aug 23
Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115 Million in Grants from the Japanese Government
12:00am
8-K
rtud031gpjk1771c5hr
7 Aug 23
Arcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress
4:23pm
8-K
EX-99.1
zv8o pwwo
7 Aug 23
Arcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress
4:23pm
8-K
09plw
14 Jul 23
Regulation FD Disclosure
7:53am
8-K
letg1r6ns h57s
30 Jun 23
Regulation FD Disclosure
8:28am